Literature DB >> 18705845

Association of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in Iranian patients with pre-eclampsia.

Mahroo Mirahmadian1, Fathollah Kalantar, Golnaz Heidari, Lili Safdarian, Reza Mansouri, Ali Akbar Amirzargar.   

Abstract

PROBLEM: Considering that certain cytokines may change during pre-eclampsia (PE), because of functional polymorphisms in their genes, our purpose was to determine the association between tumor necrosis factor-alpha (TNF-alpha) and interleukin-10 (IL-10) gene polymorphisms and development of PE. METHOD OF STUDY: The genetic polymorphisms of TNF-alpha and IL-10 was studied by polymerase chain reaction-sequence specific primers in the DNA of peripheral blood cell from 160 patients with PE and 100 healthy pregnant women.
RESULTS: We found a significant difference between TNF-alpha A allele (-308) and G allele (-238) in PE patients compared with those of the control groups. A significantly higher C/C genotype frequency of IL-10 (-592 and -819) was observed in the PE patients than in the control groups. In addition, the frequencies of three common IL-10 haplotypes (GCC, ACC, and ATA) did not show any significant difference between the study groups.
CONCLUSION: These findings would support the concept of contribution of TNF-alpha and IL-10 gene polymorphisms in the pathogenesis of PE in our population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18705845     DOI: 10.1111/j.1600-0897.2008.00610.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  8 in total

1.  Hyperresistinemia - a novel feature in systemic infection during human pregnancy.

Authors:  Shali Mazaki-Tovi; Edi Vaisbuch; Roberto Romero; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Giovanna Ogge; Bo Hyun Yoon; Zhong Dong; Juan M Gonzalez; Maria Teresa Gervasi; Sonia S Hassan
Journal:  Am J Reprod Immunol       Date:  2010-02-18       Impact factor: 3.886

2.  Association of gene polymorphisms of FV, FII, MTHFR, SERPINE1, CTLA4, IL10, and TNFalpha with pre-eclampsia in Chinese women.

Authors:  Lu Zhou; Li Cheng; Yun He; Yin Gu; Yejun Wang; Chenhong Wang
Journal:  Inflamm Res       Date:  2016-05-27       Impact factor: 4.575

3.  Maternal plasma concentration of the pro-inflammatory adipokine pre-B-cell-enhancing factor (PBEF)/visfatin is elevated in pregnant patients with acute pyelonephritis.

Authors:  Shali Mazaki-Tovi; Edi Vaisbuch; Roberto Romero; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Chia-Ling Nhan-Chang; Ricardo Gomez; Bo H Yoon; Lami Yeo; Pooja Mittal; Giovanna Ogge; Juan M Gonzalez; Sonia S Hassan
Journal:  Am J Reprod Immunol       Date:  2010-01-19       Impact factor: 3.886

4.  Association between Interleukin-10 gene polymorphisms and risk of early-onset preeclampsia.

Authors:  Limeng Song; Mei Zhong
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

5.  Role of IL-10 -819(t/c) promoter polymorphism in preeclampsia.

Authors:  Sabnavis Sowmya; Aruna Ramaiah; Tella Sunitha; Pratibha Nallari; Akka Jyothy; Ananthapur Venkateshwari
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

6.  Tumor necrosis factor-alpha polymorphism at position -238 in preeclampsia.

Authors:  Mohammad Naderi; Hanieh Yaghootkar; Fatemeh Tara; Jalil Tavakkol Afshari; Reza Farid Hosseini; Majid Ghayour Mobarhan; Abbas Shapouri Moghadam; Masoumeh Mirteimouri; Seyedeh Maryam Tara
Journal:  Iran Red Crescent Med J       Date:  2014-01-05       Impact factor: 0.611

7.  Evaluation of association of maternal IL-10 polymorphisms with risk of preeclampsia by A meta-analysis.

Authors:  Wenchao Yang; Zhenmin Zhu; Jin Wang; Wei Ye; Yong Ding
Journal:  J Cell Mol Med       Date:  2014-09-25       Impact factor: 5.310

Review 8.  Cytokine-polymorphisms associated with Preeclampsia: A review.

Authors:  Carlos Mora-Palazuelos; Mercedes Bermúdez; Maribel Aguilar-Medina; Rosalío Ramos-Payan; Alfredo Ayala-Ham; Jose Geovanni Romero-Quintana
Journal:  Medicine (Baltimore)       Date:  2022-09-30       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.